Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-13
2007-02-13
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S453000
Reexamination Certificate
active
10838157
ABSTRACT:
The present invention is based on the discovery that certain fermentation products of the marine actinomycete strains CNB392 and CNB476 are effective inhibitors of hyperproliferative mammalian cells. The CNB392 and CNB476 strains lie within the family Micromonosporaceae, and the generic epithetSalinosporahas been proposed for this obligate marine group. The reaction products produced by this strain are classified as salinosporamides, and are particularly advantageous in treating neoplastic disorders due to their low molecular weight, low IC50values, high pharmaceutical potency, and selectivity for cancer cells over fungi.
REFERENCES:
patent: 5756764 (1998-05-01), Fenteany et al.
patent: 6133308 (2000-10-01), Soucy et al.
patent: 6147223 (2000-11-01), Fenteany et al.
patent: 6214862 (2001-04-01), Fenteany et al.
patent: 6294560 (2001-09-01), Soucy et al.
patent: 6335358 (2002-01-01), Fenteany et al.
patent: 6458825 (2002-10-01), Fenteany et al.
patent: 6566553 (2003-05-01), Soucy et al.
patent: 6645999 (2003-11-01), Schreiber et al.
patent: 6794516 (2004-09-01), Soucy et al.
patent: 6838477 (2005-01-01), Schreiber et al.
patent: 6849743 (2005-02-01), Soucy et al.
patent: 2004/0138196 (2004-07-01), Fenical et al.
patent: 2005/0049294 (2005-03-01), Palladino et al.
patent: 2005/0203162 (2005-09-01), Xiao et al.
patent: 2005/0228186 (2005-10-01), Corey
patent: 2005/0288352 (2005-12-01), Potts et al.
patent: WO 96/32105 (1996-10-01), None
patent: WO 99/09006 (1999-02-01), None
patent: 02/47610 (2002-06-01), None
patent: WO 2004/071382 (2004-08-01), None
Golub et al., Science, 286, 531-537, Oct. 1999.
Feling et al., Angew. (2003) Angew. Chem. Int. Ed. 42(3):355-357.
Fusetani (ed.):Drugs from the Sea.Basel, Karger 2000, pp. 6-29.
Goodfellow and Haynes. “Actinomycetes in Marine Sediments” Ortiz-Oritz et al., ed.Biological, Biochemical, and Biomedical Aspects of Actinomycetes. Academic Press: Orlando 1984, pp. 453-472.
Davidson, B.S., Current Opinion in Biotechnology 1995, 6:284-291.
Blunt, J.W., et al., Nat. Prod. Rep., 2003, 20:1-48.
Bull, A.T., et al., Microbiol. Mol. Bio. Rev., Sep. 2000, p. 573-606.
Colquhoun, J.A., et al., Extemophiles, 1998, 2:269-277.
Fenical, W., Chem. Rev. 1993, 93:1673-1683.
Fenical, W., Marine Biotechnology 1997, 15:339-341.
Fernandez-Chimeno R.I., et al., Journal of Antibiotics, 2000 53(5):474-478.
Goodfellow and O'Donnell, (1989) Search and discovery of industrially significant actinomycetes, InMicrobial Products: New Approaches, Society for General Microbiology SymposiumNo. 44 eds Baumberg, S., et al., pp. 343-383. Cambridge: Cambridge University Press.
Goodfellow and Williams, Ann. Rev. Microbiol. 1983, 37:189-216.
Helmke and Weyland, Int. J. Syst. Bacteriol., 1984, 34(2):127-138.
Horan, A.C. “Aerobic Actinomycetes: A Continuing Source of Novel Natural Products.” In Gullo, V.P. (ed.),The Discovery of Natural Products with Therapeutic Potential. Boston: Butterworth-Heinemann, 1994, pp. 1-30.
Romero, F., et al., The Journal of Antibiotics, 1997, 50(9):734-737.
Watve, M.G. et al., 2001, Arch. Microbiol 176:386-390.
Weyland, J., Nature, 1969, 223:858.
Zheng, Z, et al., FEMS Microbiology Letters, 2000, 188:87-91.
Jensen, P.R. et al., Appl. Environ. Microbiol., 1991, 57(4):1102-1108.
Mincer, T.J., et al., Appl. Environ. Microbiol., 2002, 68(10):5005-5011.
He, H., et al., J. Am. Chem. Soc., 2001, 123:5362-5363.
Stach, J.E.M., et al., Appl. Environ. Microbiol., 2003, 69(10):6189-6200.
Colquhoun, J.A., et al., Antonie van Leeuwenhoek, 1998, 74:27-40.
Stach, J.E.M. et al., Environ. Microbiol., 2003, 5(10):828-841.
Elliot, P.J. et al., J. Mol. Med., 2003, 81:235-245.
Joseph S.J., et al., 2003, Appl Environ. Microbiol. 69(12):7210-7215.
Otoguro, M., et al., J. Appl. Microbiol., 2001, 92:118-130.
Cheng, X.C., et al., J. Nat. Prod., 1999, 62:608-610.
Cheng, X.C., et al., J. Nat. Prod. 1999, 62:605-607.
Erba, E., et al., British Journal of Cancer, 1999, 88(7):971-980.
Bernan, V.S., et al., Advances in Applied Microbiology 1997, 43:57-90.
Jenson and Fenical, Annu. Rev. Microbiol 1994, 48:559-84.
Okami, Y., Journal of Marine Biotechnology 1993, 1:59-65.
Goodfellow and O'Donnell, (1988) “Actinomycetes in Biotechnology”, Okami, et al., ed.,Search and Discovery of New Antibiotics. Academic Press: San Diego 1988, pp. 33-67.
Moran, M.A., et al., 1995, Appl. environ. Microbiol. 61(10):3695-3700.
Robert H. Feling et al., “Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Noval Microbial Source, a Marine Bacterium of the New GenusSalinospora”, Angew. Chem. Int. Ed. 2003, 42, No. 3, pp. 355-357.
Wiliam Fenical et al., “Marine Microorganisms as a Developing Resource for Drug Discovery”, Pharmaceutical News (2002), vol. 9, pp. 489-494.
Giorgio Rivieccio,“II fondo agli oceani potenti antibiotici e anticancro”, Newton, 2003, pp. 1.
Alfred L. Goldberg et al., “Not just research tools—proteasome inhibitors offer therapeutic promise”, Nature Medicine, vol. 8, No. 4, Apr. 2002, pp. 338-340.
B.J.R. Nicolaus, “Symbiotic Approach to Drug Design”, Decision Making in Drug Research, 1983, pp. 173-186.
Leleti Rajender Reddy et al., “A Simple Sterocontrolled Synthesis of Salinosporamide A”, J. Am. Chem. Soc., 2004, vol. 126, pp. 6230-6231.
Fenical et al., “Marine Microorganisms as a Biomedical Source: Are They Unculturable or Uncultured?” PowerPoint Presentation, Center for Marine Biotechnology and Biomedicine (Feb. 24, 2002).
Fenical et al., “Salinospora, a Major New Marine Actinomycete Taxon for Drug Discover.” PowerPoint Presentation, Center for Marine Biotechnology and Biomedicine (Jun. 24, 2001).
Feling Robert H. R.
Fenical William
Jensen Paul
Mincer Tracy
DLA Piper (US) LLP
Powers Fiona T.
The Regents of the University of California
LandOfFree
Salinosporamides and methods for use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Salinosporamides and methods for use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salinosporamides and methods for use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3839528